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Mouse androgenetic haploid embryonic stem cells
(AG-haESCs) can support full-term development of
semi-cloned (SC) embryos upon injection intoMII oo-
cytes and thus have potential applications in genetic
modifications. However, the very low birth rate of
SC pups limits practical use of this approach. Here,
we show that AG-haESCs carrying deletions in the
DMRs (differentially DNA methylated regions) con-
trolling two paternally repressed imprinted genes,
H19 and Gtl2, can efficiently support the generation
of SC pups. Genetic manipulation of these DKO-
AG-haESCs in vitro using CRISPR-Cas9 can produce
SCmice carrying multiple modifications with high ef-
ficiency. Moreover, transfection of DKO-AG-haESCs
with a constitutively expressed sgRNA library and
Cas9 allows functional mutagenic screening. DKO-
AG-haESCs are therefore an effective tool for the
introduction of organism-wide mutations in mice in
a single generation.
INTRODUCTION
Mammalian haploid embryonic stem cells (haESCs) (Elling et al.,
2011; Leeb andWutz, 2011) hold considerable potential as a toolCfor genetic analyses (Horii et al., 2013; Kokubu and Takeda,
2014; Leeb et al., 2014). HaESCs fall into two readily distinguish-
able types based on their origin (Shi et al., 2012): parthenoge-
netic haESCs (PG-haESCs), which bear genomic material from
the oocyte (Elling et al., 2011; Leeb and Wutz, 2011; Yang
et al., 2013), and androgenetic haESCs, (AG-haESCs) whose
genome is from the sperm (Li et al., 2012, 2014; Yang et al.,
2012).While both PG-haESCs and AG-haESCs could in principle
be used for forward or reverse genetic screens, mouse and rat
AG-haESCs can also be used in place of spermatids to support
full-term development of embryos upon injection into mature oo-
cytes (intracytoplasmic AG-haESCs injection, ICAHCI), resulting
in live animals referred to as semi-cloned (SC) animals. This ca-
pacity enables the extension of genetic analysis at a cellular level
to the organism level in one step and may open up new avenues
for efficient generation of gene-modified mice.
Recently, the CRISPR-Cas9 system from bacteria has been
widely applied to rapid genome editing in several different spe-
cies (Cong et al., 2013; Friedland et al., 2013; Mali et al., 2013;
Niu et al., 2014; Wang et al., 2013). This system, consisting of
the Cas9 nuclease and a single-guide RNA (sgRNA) targeting a
specific gene, is relatively easy to implement compared to other
gene-editing techniques (Doudna and Charpentier, 2014). Most
recently, the CRISPR-Cas9 system has been applied for efficient
loss-of-function screening in mouse and human cells (Koike-
Yusa et al., 2014; Shalem et al., 2014; Wang et al., 2014).
It seemed to us that combined application of AG-haESCs and
CRISPR-Cas9 technology could in principle enhance genetic an-
alyses in mammals. However, previous studies have shown thatell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc. 221
the efficiency of live-born SC animals was extremely low (around
4.5% of the transferred embryos in mouse and 1% in rat), and
approximately 50% of SC mice displayed a growth-retarded
phenotype and died shortly after birth (Li et al., 2012, 2014;
Yang et al., 2012). Moreover, the overall success rate of obtain-
ing live-born SC pups was reduced after long-term culturing
of AG-haESCs, especially after the type of additional culturing
period that is usually required for genetic manipulation. One
possible cause of this low efficiency is aberrant expression of im-
printed genes. These genes, which are expressed in a parental-
of-origin specific manner, are postulated to be the main block to
uniparental development (Barlow and Bartolomei, 2014) and un-
derlie the requirement for both maternal and paternal genomes
for full-term normal growth and development. Currently, approx-
imately 150 imprinted genes are known in mice, and most are
located in large clusters and regulated by differentially DNA
methylated regions (DMRs) (Bartolomei, 2009). Consistent with
this hypothesis, we previously observed loss of imprinting at
the differentially methylated region (DMR) of one paternally
repressed imprinted gene, H19, in both AG-haESCs and
growth-retarded pups (Yang et al., 2012), implying that the aber-
rant paternal imprinting state may underlie the developmental
defects of SC embryos. The maternally expressed H19 gene is
located adjacent to the paternally expressed Igf2 gene and is
regulated by a DMR that is methylated on the paternal allele
and serves as a CTCF-dependent insulator that allows expres-
sion of maternal H19. The methylation status of this DMR deter-
mines whether H19 (DMR unmethylated and active insulator) or
Igf2 (DMRmethylated and inactive insulator) is expressed. Dele-
tion of theH19 gene or DMR leads to minimal if any adverse phe-
notypes in the mouse (Leighton et al., 1995; Thorvaldsen et al.,
2002). Previous studies have also shown that deletion of the
H19 DMR (Kono et al., 2004) or the H19 DMR and Dlk1-Dio3
DMR (Kawahara et al., 2007) is the derivation of bimaternal
mice. Taking all of this information into account, we reasoned
that deletion of the H19 DMR or perhaps both H19 and Dlk1-
Dio3 DMRs from AG-haESCs might allow for more efficient gen-
eration of live SC animals using AG-haESCs.
In this study, we tested our hypothesis by removing the
DMRs from H19, Dlk1-Dio3, or both and found that the dou-
ble-knockout (DKO) AG-haESCs exhibited comparable ‘‘fertil-
ization’’ capacity to round spermatids, reaching a success rate
of 20% of transferred ICAHCI embryos. We further demon-
strated that DKO-AG-haESCs can be used in combination
with CRIPSR-Cas9 technology to generate mice with multiple
genetic modifications and with an sgRNA library for genetic
screening.
RESULTS
H19DDMR/IGDDMR AG-haESCs Efficiently Support the
Generation of Live SC Pups
To generate AG-haESCs harboring a DMR deletion in H19, we
performed nuclear transfer (NT) as previously described (Yang
et al., 2012), by injecting a haploid sperm head from
D3.8kb-50 H19 mice (Thorvaldsen et al., 2002) into an enucle-
ated oocyte instead of a somatic nucleus (Figure 1A). We
derived three haploid cell lines (referred to as H19DDMR-
AGH-1 to H19DDMR-AGH-3) from 250 reconstituted blastocysts222 Cell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc.(Figures 1B–1D and S1A) and then performed ICAHCI (Yang
et al., 2012) using the H19DDMR-AGH cells as donors. From
1,443 transferred two-cell embryos from all three H19DDMR-
AGH lines, we recovered a total of 86 apparently normal live
pups and 39 growth-retarded pups by Caesarean section
(C-section) at 19.5 days of gestation (Figures 1E and S1B–
S1D; Tables 1 and S1). The rate of normal SC mice born was
approximately 5.9% of the transferred two-cell embryos, signif-
icantly higher than the rate of control AG-haESCs, but 2.7% of
the transferred SC embryos from H19DDMR-AGH cells were
developmentally retarded.
The imprinted gene Gtl2, which resides in a large imprinted
cluster on mouse chromosome 12, is normally expressed from
the maternal allele and regulated by a paternally methylated
DMR designated intergenic germline-derived DMR (IG-DMR).
We previously observed that this gene was also expressed at
higher levels in the organs of growth-retarded SC pups pro-
duced from wild-type (WT) AG-haESCs than in control mice
(Yang et al., 2012). We then examined whether the growth-
retarded pups fromH19DDMR-AGH cells exhibited higher expres-
sion of Gtl2 in major organs by performing qPCR. As expected,
most examined organs in growth-retarded pups expressed
Gtl2 at higher levels than was expressed in normal pups (Fig-
ure S1E). Consistently, bisulfite sequencing analysis showed
that growth-retarded SC pups exhibited hypomethylation at
IG-DMR in the growth-retarded pups (Figures S1F and S1G).
Interestingly, H19DDMR-AGH cells of later passage (H19DDMR-
AGH-3, p16), which produced growth-retarded pups at a higher
frequency, harbored a more severe loss of the IG-DMR methyl-
ation than the early passage cells (H19DDMR-AGH-3, p7)
(Figure S1H; Table S1), implying that abnormal expression of
Gtl2may be an underlying factor in AG-haESCs that contributes
to the developmental failure of SC embryos generated from
H19DDMR-AGH cells.
Because deletion of the IG-DMR from Dlk1-Gtl2-imprinted
cluster in sperm did not appear to affect the development of
the resultant progeny (Lin et al., 2003) and greatly promoted
the development of bimaternal mice (Kawahara et al., 2007),
we reasoned that the deletion of IG-DMR of Dlk1-Gtl2 in
H19DDMR-AGH cells could improve the capacity of H19DDMR-
AGH cells to produce SC mice. To test this, we used CRISPR-
Cas9 technology (Wu et al., 2013). We designed two sgRNAs
targeting the 4.15-kb IG-DMR (termed IG-DMR-sgRNA1 and
IG-DMR-sgRNA2) between Dlk1 and Gtl2 of Dlk1-Gtl2 (Lin
et al., 2003) (Figure 1F). pX330-mCherry plasmids expressing
mammalian-codon-optimized Cas9 and IG-DMR-sgRNAs were
transfected into haploid H19DDMR-AGH cells, and we then
isolated 71 stable AG-haESC lines. DNA sequencing of PCR
products obtained from the amplified targeted sites showed
that IG-DMR had been successfully deleted in 58 of these lines
(termed H19DDMR-IGDDMR-AGH-1 to H19DDMR-IGDDMR-AGH-
58) (Figures 1G, S2A, and S2B). Off-target analysis of one line
(H19DDMR-IGDDMR-AGH-2) showed no mutations at a total of
22 potential ‘‘off-target’’ sites (Table S2), predicted by searching
the mouse genome according to a reported software tool (Hsu
et al., 2013). ICAHCI analysis of H19DDMR-IGDDMR-AGH cells
showed that 22.3% of SC embryos developed to term (Figures
1H, S2C, and S2D; Tables 1 and S1), similar to round spermatid
injection (ROSI) performed by us (Table 1) and others (Kishigami
Figure 1. AG-haESCs Harboring Both H19DDMR and IGDDMR Efficiently Support the Generation of Live SC Pups
(A) Diagram of SC mice generated by ICAHCI using AG-haESCs carrying H19- and IG-DMR deletions. The sperm injected into enucleated oocytes carried a
deletion of H19-DMR. PPN, pseudopronucleus derived from injected haESCs.
(B) Image of androgenetic embryos developed from an injection ofH19DDMR sperm into enucleated oocytes. A black arrow indicates a blastocyst, which had been
used for ESCs derivation. Scale bar, 50 mm.
(C) Phase-contrast image of ESCs derived from one androgenetic blastocyst. Scale bar, 100 mm.
(D) Establishment ofH19DDMR -AGH cell lines (represented byH19DDMR -AGH-1) aftermultiple rounds of FACS enrichment for haploid cells. A DAPI filter was used
to detect the signal of Hoechst-stained DNA. The left panel shows FACS data of diploid control ESCs for comparison.
(E) SC pups from ICAHCI using H19DDMR -AGH-3 cells (passage 8). Pups and placentas obtained by C-section from a pseudopregnant mouse at E19.5
are shown.
(F) Schematic of sgRNAs targeting for removal of IG-DMR. Dark green bar represents the deleted region (4.15 kb). The sequences of IG-DMR-sgRNA1 and
IG-DMR-sgRNA2 are indicated.
(G) Generation of H19DDMR- IGDDMR-AGH cells. Left, mCherry-positive cells (3.52%), which were CRISPR-Cas9-transfected cells, were enriched and plated for
derivation of AG-haESCs. Right: one established AG-haESC line (represented by H19DDMR- IGDDMR-AGH-4).
(H) SC pups from ICAHCI using H19DDMR- IGDDMR-AGH-4 cells (passage 29). Note that SC pups from H19DDMR- IGDDMR-AGH-4 cells were naturally delivered
by mothers.
See also Figures S1 and S2 and Table S1.et al., 2004). Strikingly, in contrast to the requirement for C-sec-
tion to obtain SCmice whenWT AG-haESCs orH19DDMR -AGHs
were used for ICAHCI, the pregnant females could deliver pups
by themselves and almost all SC pups born from this set of
experiments were alive and of normal size. These data demon-
strate that DKO-AG-haESCs, derived after deletion of H19 and
IG DMRs in AG-haESCs, can support high-efficiency production
of SC mice via ICAHCI.
The DMRs of H19 and Dlk1-Gtl2 Are Barriers to the
High-Efficiency Generation of SC Mice in AG-haESCs
Having achieved the high-efficiency production of SC mice
from AG-haESCs after deletion of the IG-DMR in H19DDMR-
AGH cells, we next examined whether deletion of the DMR of
Dlk1-Gtl2 alone could enable high-efficiency production of SCCmice in AG-haESCs. To this end, we generated AG-haESCs
from IG-DMR KO mice (Lin et al., 2003) by performing NT. A
total of eight haploid ESC lines were derived, in which two lines
harbored a mutant IG-DMR (referred to as IGDDMR-AGH-1 and
IGDDMR-AGH-2). ICAHCI analysis showed that IGDDMR-AGH
cells were not efficient donors for producing SC pups (Tables 1
and S1); SC pups with normal size were rarely obtained
(i.e., only 4 of 499 transferred SC embryos) (Figures 2A and
S2E). Instead, most pups were growth retarded. Interestingly,
methylation of the H19 DMR was reduced in IGDDMR-AGH cells
and absent in growth-retarded pups (Figures 2B, S2F, and
S2G). We then removed the 3.8-kb DMR of H19 (Thorvaldsen
et al., 2002) in IGDDMR-AGH cells using the CRISPR-Cas9 sys-
tem and generated 13 DKO-AG-haESC lines (termed IGDDMR-
H19DDMR-AGH-1 to IGDDMR-H19DDMR-AGH-13) (Figures 2Cell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc. 223
Table 1. Summary of In Vivo Development of ICAHCI Embryos Derived from Haploid Cells Carrying Different Gene Modifications
Donor Cell Type Haploid ESC Line
Passage
Number
No. of Embryos
Transferred
No. of Growth-Retarded
Pups (% of Transferred
Embryos)
No. of Normal Pups
(% of Transferred
Embryos)
Single DMR KO AG-haESCs H19DDMR-AGH cells p8-p17 1443 39 (2.7) 86 (5.9)c
IGDDMR-AGH cells p8-p23 499 12 (2.4) 4 (0.8)
DKO-AG-haESCs H19DDMR-IGDDMR-AGH cells p19-p33 939 4 (0.4) 210 (22.4)
IGDDMR-H19DDMR-AGH cells p24-p28 544 5 (0.9) 105 (19.3)
H19DDMR-IGDDMR-AGH-OG3
cells
p26-p37 510 1 (0.2) 87 (17.1)
subtotal p19-p37 1993 10 (0.5) 402 (20.2)d
DKO-AG-haESCs carrying
Tet 1, 2, and 3 triple
mutations
Tet-TKO-DAH cells p35-p37 407 4 (1.0) 59 (14.5)
DKO-AG-haESCs carrying
p53, 63, and 73 triple
mutations
p53-TKO-DAH cells p41-p46 660 2 (0.3) 111 (16.7)
DKO-AG-haESCs carrying
Tet1 and 3 Knockin
Tet1&3-KI-DAH-1 p40-p47 138 1 (0.7) 21 (15.2)
DKO-AG-haESCs carrying
Tet1, 2, and 3 Knockin
Tet-TKI-DAH-1 p47-p51 874 6 (0.7) 151 (17.3)
WT AG-haESCs AGH cellsa p9-p20 294 3 (1.0) 2 (0.7)
AGH-OG-3 cellsb p12-p26 379 6 (1.6) 7 (1.8)
Control round spermatids 125 0 28 (22.4)
See also Figures S1–S5 and Tables S1 and S3.
aAG-haESCs generated in this study.
bAG-haESCs generated in our previous study.
cH19DDMR-AGH cells versus WT AG-haESCs (p < 0.05).
dDKO-AG-haESCs versus WT AG-haESCs (p < 0.001).and S2H; Table S2). ICAHCI analysis of two lines showed
comparable potential to that of H19DDMR-IGDDMR-AGH cells
for generating normal SC pups (Figures S2I and S2J; Tables 1
and S1).
Next, we asked whether the capacity for high-efficiency pro-
duction of SC mice could be re-established in late-passage
WT AG-haESCs by removing the DMRs of H19 and IG simulta-
neously. To this end, we chose a WT AG-haESC line, AGH-
OG-3, which almost completely lost its ability to produce normal
SC mice by ICAHCI by passage 22 (Yang et al., 2012) (Table S1).
After transfection of plasmids expressing Cas9 and sgRNAs de-
signed for targeting DMRs ofH19 and IG (Figures 1F and 2C) into
passage 21 AGH-OG-3 cells, we generated 12 AG-haESC lines
carrying deletions of both DMRs (termed H19DDMR-IGDDMR-
AGH-OG3-1 to H19DDMR-IGDDMR-AGH-OG3-12) (Figures 2D
and S3A; Table S2). Strikingly, after injection of haploid cells
from two of these lines into oocytes, around 17% of the resulting
embryos could develop normally to term (Figures S3B and S3C;
Tables 1 and S1), indicating that WT AG-haESCs that had previ-
ously lost the ability to produce live SC mice regained it after
removal of the H19 and IG DMRs.
A total of 402 SC pups were born from three sets of DKO-AG-
haESCs, at an average efficiency of 20.2% of transferred
embryos. SC pups generated from DKO-AG-haESCs grew to
adulthood and reproduced normally. Genotype analyses of 33
live-born pups from seven litters of progeny delivered by SC
mice showed that 13 carried the mutant H19-DMR and 11224 Cell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc.were WT (Figure 2E). Another nine pups, in which six carried
mutant IG-DMR and three carried mutations in both H19 and
IG DMRs (Figure 2E), died shortly after birth, conforming to the
expected phenotype of postnatal or neonatal lethality induced
by maternal transmission of the IG-DMR deletion (Lin et al.,
2003). These data demonstrate that removing the H19 and IG
DMRs does not impede normal development and reproduction
in the resulting SC pups and elimination of the DMR deletions
in the progeny of SC mice can be naturally obtained by further
crossing with WT animals.
Next, we tested whether deletion of the DMRs changed gene
expression in AG-haESCs. qPCR analysis showed that H19 and
Gtl2 were downregulated, while Igf2 and Dlk1 were upregulated
in DKO-AG-haESCs, as expected based on the DMR deletions
(Figure S3D). Next, we compared the gene expression profiles
of DKO-AG-haESCs with those of normal AG-haESCs and
mouse round spermatids (RSs). Clustering of these cells based
on RNA sequencing (RNA-seq) data showed a high correlation
between DKO-AG-haESCs and WT AG-haESCs, but not
RSs (Figures 2F and S3E). We further compared the expres-
sion patterns of other imprinted genes in DKO-AG-haESCs and
control AG-haESCs and found that DKO-AG-haESCs and
WT AG-haESCs exhibited highly similar expression profiles
across all imprinted genes (Figure 2G). To further assess
epigenetic inheritance, we performed reduced representation
bisulfite sequencing (RRBS) to determine the methylomes at
base resolution on a genome-wide scale. As shown in Figures
Figure 2. H19 and IG DMRs Are Two Barriers to the High-Efficiency Generation of SC Pups in AG-haESCs
(A) SC pups from IGDDMR-AGH-1 cells (passage 17). Pups and placentas obtained by C-section from a pseudopregnant mouse at E19.5 are shown. Asterisks
indicate growth-retarded SC pups that died shortly after birth.
(B) Methylation state of the H19-DMR in a normal SC pup (left) and a retarded pup (right) derived from IGDDMR-AGH-1 cells.
(C) Schematic of sgRNAs targeting for the removal of H19-DMR. A pink bar represents the deleted region (3.8 kb). The sequences of H19-DMR-sgRNA1 and
H19-DMR-sgRNA2 are indicated.
(D) Genotyping analysis of H19DDMR-IGDDMR-AGH-OG3 cells. Note that these cells were generated by deletion of both IG-DMR and H19-DMR in WT AGH-OG-3
(passage 21) that have lost the ability to produce SC pups after injection into oocytes (Yang et al., 2012).
(E) Genotyping analysis of the progeny of SC mice derived from DKO-AG-haESCs. Note that pups carrying mutant IG-DMR or mutations in both H19 and IG died
shortly after birth.
(F) Gene expression profiles of DKO-AG-haESCs using RNA-seq analysis. Gene expression profiles were clustered using all expressed genes. Three DKO-
AG-haESC lines generated by different strategies show highly similar expression profiles to the control AG-haESCs, although they are markedly different
from mouse round spermatids (RSs). AGH-2 is a WT haploid cell line established in this study. AGH-OG-3 is a WT haploid cell line that was established in our
previous study (Yang et al., 2012). To avoid the influence of diploidized cells on the expression profile, we collected samples after FACS of cells in the G1/G0
phase.
(G) Gene expression profiles of DKO-AG-haESCs based on imprinting genes. Three DKO-AG-haESC lines show highly similar expression profiles to the control
AG-haESCs, although they are markedly different from mouse RSs.
(H) Methylation profiles of DKO-AG-haESCs based on RRBS analysis. The pies show different methylation levels of CpG sites in different colors.
See also Figures S2 and S3 and Table S1.2H, S3F, and S3G, deletion of H19 and IG DMRs did not change
themethylation patterns in AG-haESCs based on the analyses of
all detected CpGs and the promoter regions of all imprinted
genes. Taken together, our results demonstrate that the DMRsCof H19 and IG are major barriers to high-efficiency production
of SC mice in AG-haESCs and their deletion does not have
notable negative effects on the gene expression profile of
functionality.ell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc. 225
Figure 3. DKO-AG-haESCs Carrying Multiple Gene Modifications Support Efficient Generation of SC Mice
(A) Schematic of Cas9-sgRNA-targeting sites in Tet1, 2, and 3. The sgRNA-targeting sequences are underlined, and the PAM sequences are labeled in red.
(B) MCherry-positive cells (3.96%), which were CRISPR-Cas9-transfected cells, were enriched and plated for derivation of DKO-AG-haESCs carrying mutant Tet
genes.
(C) Generation of Tet-TKO-DAH cells. Left: phase-contrast image of ESCs derived by expansion of single cells. Right: flow analysis of an established haploid cell
line. Scale bar, 100 mm.
(D) The sequences of Tet1, 2, and 3 in Tet-TKO-DAH-1 cells. Deletions are indicated with ().
(E) DNA sequences of PCR products amplified from Tet1, 2, and 3 genes of two SC pups generated from Tet-TKO-DAH-1 and Tet-TKO-DAH-2, respectively. Two
peaks can be observed in the sequences of the SC pups carrying heterogeneous mutations in Tet1, 2, and 3.
(F) Schematic of Cas9-sgRNA-targeting sites in p53, 63, and 73. The sgRNA-targeting sequences are underlined, and the PAM sequences are labeled in red.
(G) The sequence of p53, 63, and 73 in p53-TKO-DAH-2. Deletions are indicated with ().
(H) Schematic of double-stranded vectors, including Tet1-EGFP, Tet2-mCherry, and Tet3-ECFP. EGFP,mCherry, and ECFP reporters fused with the last codon
of the Tet1, Tet2, and Tet3 genes, respectively.
(I) Genotyping analysis of Tet-TKI-DAH-1 cells.
See also Figures S4 and S5 and Table S3.Generation of Mutant Mice Carrying Multiple Genetic
Modifications Using DKO-AG-haESCs
Having demonstrated the stable developmental potential of
DKO-AG-haESCs by ICAHCI, we next examined whether multi-
ple genetic alterations can be introduced into these DKO-AG-
haESCs, followed by ICAHCI to efficiently produce SC mice
carryingmultiple mutations. For this experiment, we first attemp-
ted disruption of Tet1, Tet2, and Tet3 in DKO-AG-haESCs using
the CRISPR-Cas9. We transfected constructs expressing Cas9
and three sgRNAs targeting Tet1, 2, and 3 (Figure 3A) (Wang
et al., 2013) into DKO-AG-haESCs, leading to 56 stable DKO-
AG-haESC lines. DNA sequencing of PCR products correspond-
ing to amplified targeted sites showed that Tet1, 2, and 3 were
successfully mutated in 18 cell lines (termed Tet-TKO-DAH-1
to Tet-TKO-DAH-18) (Figures 3B–3D and S4A). ICAHCI analysis226 Cell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc.of four of the cell lines showed that SCmice carryingmutations in
Tet1, 2, and 3 could be generated at an appropriate efficiency
(Figures 3E and S4B; Tables 1 and S3). We further confirmed
this by generation of DKO-AG-haESCs carrying mutations in
the p53 family (Figures 3F, 3G, and S4C) and efficient production
of corresponding SC pups via ICAHCI (Figures S4D and S4E; Ta-
bles 1 and S3). These data demonstrate that DKO-AG-haESCs,
unlike WT AG-haESCs that fail to produce live SC mice after
being genetically manipulated in vitro (Yang et al., 2012), can
efficiently and stably support the generation of SCmice following
genome engineering.
Next, we tested whether precise gene-modification experi-
ment by insertion of DNA constructs into multiple endogenous
genes was feasible in DKO-AG-haESCs and could further lead
to SC mice carrying corresponding genetic traits. For this, we
attempted to derive DKO-AG-haESCs carrying a fluorescent
reporter constructs knocked into the endogenous Tet1, 2, and
3 loci. We first transfected DKO-AG-haESCs with constructs ex-
pressing both Cas9 and two sgRNAs targeting Tet1 and 3 (Fig-
ure 3A) and double-stranded donor vectors that were designed
to fuse an EGFP reporter with the last codon of the Tet1 gene
and an ECFP reporter with the last codon of the Tet3 gene (Fig-
ures 3H and S5A). A total of 150 DKO-AG-haESC lines were
generated, and 10 and 7 cell lines carried the EGFP reporter
gene in the Tet1 and ECFP reporter gene in the Tet3 loci, respec-
tively (Figures S5B and S5C). One cell line, termed Tet1&3-KI-
DAH-1, carried both Tet1-EGFP and Tet3-ECFP genes (Figures
S5D and S5E). ICAHCI analysis with this line produced SC
mice carrying the Tet1-EGFP and Tet3-ECFP knockin alleles
with similar efficiency to ICAHCI with WT DKO-AG-haESCs
(Figures S5F and S5G; Tables 1 and S3). Next, we transfected
Tet1&3-KI-DAH-1 cells with constructs expressing both Cas9
and an sgRNA-targeting Tet2 and a double-stranded donor vec-
tor of a mCherry reporter fused with the last codon of the Tet2
gene (Figures 3A and 3H). From 130 established cell lines, we
identified eight haploid cell lines with a Tet2-mCherry insertion
(Tet-TKI-DAH-1 to Tet-TKI-DAH-8) (Figures 3I and S5H). We
investigated the developmental potential of these Tet-TKI-DAH
cells by ICAHCI and found that they reproducibly produced
live SC pups after injection into oocytes (Figures S5I and S5J;
Tables 1 and S3). Taken together, these results indicate that
DKO-AG-haESCs are a feasible tool for multiple-site genetic
modification using CRIPSR-Cas9 and ICAHCI to give pups car-
rying the corresponding genetic traits.
DKO-AG-haESCs Carrying an sgRNA Library Generate
Heterozygous Mutant Mice
Recent studies have shown an application of genome-wide
sgRNA libraries for loss-of-function screening in human and
mouse cells (Koike-Yusa et al., 2014; Shalem et al., 2014;
Wang et al., 2014). Based on that, we reasoned that DKO-AG-
haESCs carrying an sgRNA library might be used to efficiently
generate mutant mouse models by ICAHCI (Figure 4A; termed
the ‘‘lenti-sgRNA+pX330’’ strategy). To test this, we employed
a well-characterized, recently established mouse lentiviral
sgRNA library (Koike-Yusa et al., 2014) that contains 87,897
sgRNAs targeting 19,150 mouse protein-coding genes. 1.0 3
107 FACS-enriched haploid cells from the IGDDMR-H19DDMR-
AGH-2 cell line were infected with the genome-wide sgRNA len-
tiviral library. Two days later, transfected cells were selected
by puromycin treatment, followed by transfection of pX330-
mCherry plasmids expressing Cas9. Haploid cells expressing
mCherry, in which Cas9 was successfully transfected, were en-
riched (Figure 4B) and used for subsequent ICAHCI analysis. To
examine whether genes were mutated by CRISPR-Cas9 in
haploid cells, we randomly analyzed seven haploid cell clones.
All tested clones carried one sgRNA, and DNA sequencing anal-
ysis indicated that the targeted genes were mutated, reflecting a
successful induction of gene mutation by CRISPR-Cas9 in
haploid cells (Figures 4C and 4D).
Next, we tested whether these haploid cells that carried
mutant genes support efficient generation of heterozygous
mice by ICAHCI. A total of 114 SC pups were produced from
three independent ICAHCI experiments (Figure 4E; Table 2), ofCwhich 82 SC pups carried only one sgRNA (Figure 4F). DNA
sequencing of PCR products amplified from sgRNA-targeted
sites indicated that 43 SC pups carried mutant genes at one tar-
geted allele, of which 39were frameshift insertion/deletion (indel)
mutations that result in a loss-of-function allele (Figure 4G; Data
S1). Interestingly, all mutant alleles exhibited one genotype,
reflecting the fact that the gene was mutated in the individual
haploid cells after transient expression of Cas9, which were
then injected into WT oocytes to produce SC embryos. The re-
maining 39 SC pups carried an sgRNA but failed to show target
site mutations, a frequency similar to previous observations in
human cells (Zhou et al., 2014) or in mouse embryos (Wu et al.,
2013). These data therefore demonstrate that DKO-AG-haESCs
carrying an sgRNA library, when transiently infected with Cas9,
can introduce genetic mutations into the resulting SC mice
through ICAHCI, leading to the one-step generation of heterozy-
gous mutant mice.
Generation of BiallelicMutantMiceUsing sgRNALibrary
DKO-AG-haESCs
Next, we tested whether DKO-AG-haESCs carrying an sgRNA
library can be used to produce biallelic mutant mice by ICAHCI.
For this approach, we performed ICAHCI first by injecting
haploid cells carrying an sgRNA library into mature oocytes
and then injected Cas9 mRNA into reconstructed oocytes
(termed the ‘‘lenti-sgRNA+Cas9 injection’’ strategy). A total of
51 SC pups carrying one sgRNA were generated, and 22 of
them carried mutant genes (Table 2; Data S1). DNA sequencing
of PCR products with specific primers from tail genomic
DNA showed that ten mice carried monoallelic modifications
and 12 carried biallelic modifications (23.5% of total born
SC pups). We then performed TA cloning and sequencing
analysis of seven pups with biallelic mutations and found that
around 63% of tested clones carried frameshift indel mutations
(Table S4).
To increase the biallelic mutation rate of SC pups, we then
conducted double Cas9 treatment by injecting haploid cells
carrying sgRNA that been transiently transfected with pX330-
mCherry plasmid (expressing Cas9) into mature oocytes fol-
lowed by injection of Cas9 mRNA into reconstructed oocytes
(Figures S6A and S6B) (termed the ‘‘lenti-sgRNA+pX330+Cas9
injection’’ strategy). We derived a total of 31 SC pups carrying
one sgRNA, and 22 of them carried mutations (Figures S6C
andS6D; Table 2; DataS1), ofwhich 13were biallelic (Figure S6E)
(41.9%of total born SC pups) and 9weremonoallelic. TA cloning
and sequencing analysis of five pups with biallelic mutations
showed that around 79% of tested clones carried frameshift
indel mutations (Figures S6F and S6G; Table S4).
As recent studies have shown that constitutive expression of
Cas9 does not affect the viability of cells and mice (Koike-Yusa
et al., 2014; Platt et al., 2014), we also tested a third strategy in
which DKO-AG-haESCs with constitutive expression of Cas9
and an sgRNA library were generated by two rounds of drug se-
lection and then used for production of SC mice by ICAHCI (Fig-
ures 5A–5D) (termed strategy of ‘‘lenti-Cas9+lenti-sgRNA’’). We
reasoned that this strategy would greatly enhance the likelihood
of obtaining biallelic mutant mice from DKO-AG-haESCs.
Among the 1,453 SC embryos that we reconstructed via ICAHCI,
272 (18.7%) developed to term in vivo (Figure 5E; Table 2), similarell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc. 227
Figure 4. DKO-AG-haESCs Carrying an sgRNA Library Support the Efficient Generation of Heterozygous Mutant Mice in One Step
(A) Schematic of the efficient generation of heterozygous mutant SC mice via ICHACI using DKO-AG-haESCs carrying an sgRNA library in one step.
(B) Haploid cells expressing mCherry (15.8%), in which Cas9 were successfully transfected, enriched, and used for subsequent ICAHCI analysis.
(C) PCR analysis of sgRNA in haploid cell clones expanded from single cells. All tested clones carried sgRNA.
(D) The sequences of different targeted genes in cell clones. Gene modifications existed in the targeted genes in all tested clones.
(E) SC pups from DKO-AG-haESCs carrying an sgRNA library. Note that SC pups were naturally delivered by mothers.
(F) PCR analysis of existence of sgRNA in SC pups.
(G) The sequences of different targeted genes in SC pups. Gene modifications existed in the targeted genes in tested SC pups.
See also Data S1.to the ICAHCI efficiency for WT DKO-AG-haESCs or DKO-
AG-haESCs carrying different genetic modifications (Table 1),
indicating that multiple rounds of genetic manipulations in
DKO-AG-haESCs do not affect the developmental potential of
resulting SC embryos. A total of 224 SC pups carrying one
sgRNA were subjected to genotyping analysis (Figure 5F; Ta-
ble 2; Data S1). The results showed that 143 of them carried mu-
tations, of which 83 were biallelic (Figure 5G). We also produced
60monoallelic mutant mice even though Cas9 is supposed to be
constitutively expressed in this system, probably because of
silencing of the lentiviral vectors (Ellis, 2005; Koike-Yusa et al.,
2014). We performed TA cloning and sequencing of targeted
genes in tails of 26 mutant mice and found around 66.3% of
tested clones carried frameshift indels (Figures 5H and 5I; Table
S4). To examine the whole-body mutation rate in the SC pups,
we conducted genotyping in different organs, including brain,
heart, kidney, liver, and lung dissected from four SC pups and
found that all organs carried biallelic mutations. Finally, we per-
formed TA cloning and sequencing in all of the organs of one
SC pup that carried Scube1 genemutations. The results showed
that more than 80% of tested clones carried frameshift indel mu-
tations (Figure 5J). Interestingly, this mouse died 1 hr after birth,228 Cell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc.consistent with a previous report on Scube1 mutant mice
(Tu et al., 2008). Taken together, our results provide a proof of
principle that mutant mice can be obtained via ICAHCI using
DKO-AG-haESCs that harbor an sgRNA library and that this
approach could be used for KO-based screens in mouse.
DISCUSSION
Our previous studies (Yang et al., 2012) showed that AG-
haESCs can be derived from haploid AG-blastocysts and
support the generation of SC mice via ICAHCI. However, AG-
haESCs failed to produce live-birth SC pups upon long periods
of culturing, especially through the course of in vitro genetic
manipulation, probably due to the loss of paternal imprints. In
this study, we show the high-efficiency generation of SC pups
upon removal of DMRs of H19 and IG in AG-haESCs, leading
to stable production of live SC mice via ICAHCI at a rate
of 20%, 10 times higher than with the WT AG-haESCs
even from early passages (Table 1) (Yang et al., 2012). Impor-
tantly, we also show that DKO-AG-haESCs can be used for
genetic manipulation to produce, via ICAHCI, SC mice carrying
multiple gene modifications at a comparable efficiency to WT
Table 2. Summary of SC Mice Derived from DKO-AG-haESCs Carrying an sgRNA Library
Strategies
No. of
Embryos
Transferred
No. of SC Pups
(% of Transferred
Embryos)
No. of SC
Pups without
sgRNA
No. of SC Pups
Carrying sgRNA
(nR 2)
No. of SC Pups
Carrying One
sgRNA
No. of SC Pups
with Biallelic
Mutation
No. of SC Pups
with Monoallelic
Mutation
lenti-sgRNA+pX330 580 114 (19.7) 11 21 82 0 43
lenti-sgRNA+Cas9
injection
306 51 (16.7) 0 4 47 12 10
lenti-sgRNA+pX330+
Cas9 injection
238 31 (13.5) 3 1 27 13 9
lenti-Cas9+lenti-sgRNA 1,453 272 (18.7) 22 13 237 83 60
See also Figure S6, Table S4, and Data S1.DKO-AG-haESCs. Moreover, when combined with an sgRNA
library, DKO-AG-haESCs can be used to generate monoallelic
and biallelic mutant mice.
DKO-AG-haESCs have a number of advantages over existing
technologies for production of gene-modified mice. First, DKO-
AG-haESCs-mediated gene editing provides a unique system
in which gene-modified DKO-AG-haESCs can be analyzed and
pre-selected, ensuring the generation of SC pups with uniform
modifications and avoiding somatic mosaicism induced by
direct injection of CRISPR-Cas9 into zygotes (Niu et al., 2014;
Wang et al., 2013). Second, thanks to the efficiency and reliability
of SC mouse generation by ICAHCI, our system can produce
sufficient numbers of offspring for analysis in one generation.
Third, application of DKO-AG-haESCs carrying an sgRNA library
and expressing Cas9 can be used for genetic screening. SC
pups carrying different mutations can be easily identified by
PCR of the integrated sgRNA (just like a ‘‘barcode’’ of themutant
mouse) using one pair of common primers for sgRNA. Appli-
cation of this approach for large-scale screens based on a
genome-wide production of mutant mice is not yet feasible at
present, due to three significant hurdles: (1) the overall efficiency
of generating biallelic mutants through DKO-AG-haESCs
carrying sgRNA needs to be further improved; (2) it would be
extremely time- and labor-consuming to generate a genome-
wide mutant mouse library using this approach; and (3) the
subsequent phenotype analysis of the mutant mice would be a
complex task. In addition, culture of AG-haESCs and fertilization
by ICAHCI are technologies that are not in use by many groups
and successful application of this approach requires proficiency
in them both. Nevertheless, we would like to propose that it
is feasible to use our approach for medium-scale targeted
screening at organism level, especially for developmental phe-
notypes, using the appropriate sgRNA libraries targeting pre-
selected candidate genes.
In summary, the generation of SC mice using DKO-AG-
haESCs is an efficient and simple method for producing mouse
models carrying complex genetic modifications, such as muta-
tions or knockin reporters in multiple members of a gene family.
Moreover, together with an sgRNA library, DKO-AG-haESCs
enable efficient generation ofmutantmice in a single step. Future
analyses will be needed to understand the detailed mechanism
underlying the high-efficient generation of SC mice by DKO-
AG-haESCs. In the meantime, we hope that the method we
have developed will facilitate genetic analysis of development
and modeling of diseases in mice.CEXPERIMENTAL PROCEDURES
Animal Use and Care
All animal procedures were performed under the ethical guidelines of the
Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological
Sciences, Chinese Academy of Sciences.
Derivation of AG-haESCs
For generation of AG-haploid embryos, spermatozoa of H19-DMR KO mice
(C57/B6 background, homozygous) (Thorvaldsen et al., 2002) or IG-DMR KO
mice (C57/B6 background, heterozygous) (Lin et al., 2003) were collected for
NT according to the previously reported methods (Yang et al., 2012). Briefly,
mature oocytes were obtained from superovulated B6D2F1 (C57BL/6 3
DBA2) female mice and enucleated in a droplet of HEPES-CZB medium con-
taining 5 mg/ml cytochalasin B (CB) using a blunt Piezo-driven pipette. After
enucleation, a single sperm head was injected into oocyte cytoplasts. The re-
constructed oocytes were cultured in CZB medium for 1 hr and then activated
for 5–6 hr in activation medium containing 10mMSr2+. Following activation, all
of the reconstructed embryoswere cultured inKSOMmediumwith aminoacids
at 37C under 5% CO2 in air. The reconstructed embryos that reached the
morula or blastocyst stage by 3.5 days in culture were transferred into ESC
medium for derivation of ESC lines as previously described (Yang et al.,
2010). The zona pellucida was removed using acid Tyrode solution. Each
embryo was transferred into one well of a 96-well plate seeded with ICR
embryonic fibroblast feeders in ESC medium supplemented with 20%
knockout serum replacement, 1,500 U/ml LIF, 3 mM CHIR99021, and 1 mM
PD0325901. After 4–5 days in culture, the colonies were trypsinized and trans-
ferred to a 96-well platewith a fresh feeder layer in freshmedium.Clonal expan-
sion of the ESCs proceeded from 48-well plates to 6-well plates with feeder
cells and then in 6-well plates for routine culture. To sort haploid cells, ESCs
were trypsinized, washed by DPBS (GIBCO), and then incubated with
15 mg/ml Hoechst 33342 in a 37C water bath. Subsequently, the haploid 1C
peak was purified using BD FACS AriaII for further culturing.
CRISPR-Cas9-Mediated Gene Manipulation in Haploid Cells
To generate CRISPR-Cas9 plasmid for gene mutation, sgRNAs of target
genes were synthesized, annealed, and ligated to the pX330-mCherry
plasmid that was digested with Bbs I (New England Biolabs). AG-haESCs
were transfected with corresponding pX330-mCherry plasmids, including
sgRNA using Lipofectamine 2000 (Life Technologies) in accordance with
the manufacturer’s instruction manual. 48 hr after transfection, the haploid
cells expressing red fluorescence protein were enriched with flow cytome-
try (FACS AriaII, BD Biosciences) and plated at low density. 4–5 days
after plating, single colonies were picked for derivation of AG-haESCs.
Haploid cell lines carrying expected genotypes were selected for further
analysis by DNA sequencing of PCR products amplified from targeted sites
(Table S5).
For the construction of double-stranded DNA donors, the sequences
encoding EGFP, mCherry, or ECFP were amplified and ligated to the
pMD19T vector, respectively. Subsequently, the sequences of left arms and
right arms of targeted genes were inserted into the multiple cloning sites
(MCS) of pMD19T-EGFP/mCherry/ECFP vectors, respectively.ell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc. 229
Figure 5. DKO-AG-haESCs Carrying Constitutively Expressed Cas9 and an sgRNA Library Support the Efficient Generation of Biallelic
Mutant SC Mice in One Step
(A) Schematic of efficient generation of biallelic mutant SCmice via ICHACI using DKO-AG-haESCs carrying constitutively expressed Cas9 and an sgRNA library.
(B) PCR analysis of Cas9 in haploid cell clones expanded from single cells. All tested clones carried Cas9 transgene.
(C) qPCR analysis of Cas9 expression in cell clones expanded from single cells. Cas9 were expressed in all tested cell clones.
(D) PCR analysis of sgRNA in haploid cell clones expanded from single cells. All tested clones carried sgRNA.
(E) SC pups from DKO-AG-haESCs carrying constitutively expressed Cas9 and an sgRNA library. Note that SC pups were naturally delivered by mothers.
Left: newborn SC pups. Right: adult SC mice.
(F) Identification of sgRNA in SC mice by PCR analysis.
(G) Generation of biallelic mutant mice via ICAHCI using DKO-AG-haESCs carrying constitutively expressed Cas9 and an sgRNA library. One represented SC
mouse carries biallelic mutant Polm gene, indicated by multiple peaks in the sequence of PCR products.
(H) Sequence of the targeted Polm gene in the mouse tail by TA cloning and sequencing analysis. 24 of 26 tested clones carried frameshift insertion/deletion
(indel) mutations.
(I) Summary of TA cloning and sequencing analysis of seven biallelic mutant mice. Over 80% of tested clones carried frameshift indels.
(J) TA cloning and sequencing analysis of different organs in onemouse carrying biallelic mutant Scube1 gene. Over 80%of tested clones carried frameshift indel
mutations. More than 30 clones were tested for each organ.
See also Figure S6, Table S4, and Data S1.Lentiviral Infection of Haploid Cells
The lenti-sgRNA library and lenti-Cas9 plasmids were reported previously
(Conget al., 2013; Koike-Yusa et al., 2014) andprovidedbyAddgene. For prep-
aration of the lentivirus, the HEK293T cells in a 10-cm dish were transfected
with 3mgof a lentiviral vector (lenti-sgRNA library or lenti-Cas9) and 9mgof Vira-
Power Lentiviral Packaging Mix (Invitrogen) by Lipofectamine 2000 Reagent
(Invitrogen) in accordance with the manual. The supernatant was harvested
72 hr after transfection, concentrated with Lenti-Concentin virus precipitation230 Cell Stem Cell 17, 221–232, August 6, 2015 ª2015 Elsevier Inc.solution (SBI), and then stored at 80C. In order to determine the virus vol-
umes for achieving an MOI of 0.3 to ensure that most cells receive single
copy of the lentiviral vector, DKO-AG-haESCs in 24-well plates were incubated
with different volume of lentivirus. Then the 108 suspended cells were infected
in ESCmedium supplementedwith 8 mg /ml polybrene (Sigma) and optimal vol-
ume of lentivirus for 48 hr. After selection in ESCmedium containing puromycin
(Invitrogen) or blasticidin (Sigma), the cells were collected for genomic DNA
extraction and sorted for injection. To mutate the DKO-AG-haESCs without
Cas9 integration, the cells were further transfected with pX330-mCherry
plasmid and sorted with FACS to enrich the mCherry-positive cells.
ICAHCI, ROSI, and Embryo Transfer
To generate semi-cloned (SC) embryos, AG-haESCs arrested at M phase by
culturing in medium containing 0.05 mg/ml demecolcine for 8 hr were used for
intracytoplasmic injection. AG-haESCs were trypsinized, washed three times
with HEPES-CZBmedium, and suspended in HEPES-CZBmedium containing
3% (w/v) polyvinylpyrrolidone. Each nucleus from M-phase haploid cells was
injected into anMII-arrestedoocyte usingaPiezo-drillmicromanipulator (Movie
S1). The reconstructed oocytes were cultured in CZBmedium for 1 hr and then
activated for 5–6 hr in activationmediumwithout CB. Following activation, all of
the reconstructedembryoswere cultured inKSOMmediumwith amino acids at
37Cunder 5%CO2 in air. ICAHCI embryoswere cultured in KSOMmedium for
24 hr to reach the two-cell stage. For ROSI, we adopted a reported protocol by
Kishigami et al. (2004). 15–20 two-cell embryos derived from ICAHCI or ROSI
were transferred into each oviduct of pseudo-pregnant ICR females at
0.5 days postcoitum (dpc). Recipient mothers were euthanized at 19.5 days
of gestation, and the pups were quickly removed from the uteri (for embryos
derived from WT AG-haESCs or AG-haESCs carrying single DMR deletion) or
naturally delivered (for embryos derived from ROSI or DKO-AG-haECs). After
cleaning fluid from their air passages, the pups were kept in a warm box sup-
plied with oxygen. Surviving pups were raised by lactating mothers.
Statistical Analysis
Differences of generation of SC pups between groups were analyzed by
means of Student’s t test.
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